Lin S.

Lin S. is a Senior Scientist I at Beam Therapeutics since April 2023, with previous roles as a Scientist II in NGS at ICON Specialty Labs and Senior Research Scientist at Massachusetts General Hospital. Lin's research includes revealing transcriptional networks regulated by glucose-TOR signaling in Arabidopsis, uncovering significant stress and immune signaling mechanisms, and conducting extensive RNA-seq and ChIP-seq analyses. Educational credentials include a Ph.D. in Plant Molecular Genetics and Biochemistry from The University of British Columbia, an MPhil in Biology and Chemistry from City University of Hong Kong, and a BSc in Biochemistry from Nankai University.